Request Sample Report

View Synopsis & Table of Content
{reportSlug=global-moyamoya-disease-market, reportId=126829, mktKeyword=Moyamoya disease, cagr=0.00, publishDate=Nov 2022, priceOption2=7500, reportTitle=Moyamoya disease Comprehensive Study by Type (Ischemic, Hemorrhagic, Epileptic, Other), Treatment (Non-Surgical {Anti-seizure medications, and Calcium channel blockers}, Surgical {Vascular bypass surgery, and Cerebral Revascularization }), Age Group (5 to 10 years in children, 30 to 50 years in adults, Other), Diagnosis (Cerebral angiogram, Magnetic resonance imaging (MRI), Magnetic resonance angiography (MRA), Computed tomography (CT), Positron emission tomography (PET), Electrocardiography ECG, Transcranial Doppler ultrasound), Surgical Procedure (Indirect {Encephalomyosynangiosis (EMS), Encephaloduroarteriosynangiosis (EDAS)}, Direct {Suturing of a scalp blood vessel, the superficial temporal artery}), Distribution channel (Hospital, Surgical Centers, Diagnostic clinics, Others) Players and Region - Global Market Outlook to 2027, baseYr=2021, totalTableFig=212, priceOption1=3750, forecastYr=2027, noOfPages=215, reportKey=126344, breadcrum=Global Moyamoya disease Market}
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Select User Access Type

Key Highlights of Report


Nov 2022 215 Pages 63 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Connect with Us
AMA Research Sales Support

Praveen Kumar

Head - Sales